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 Introduction 
Approximately 25 % of the babies born in developing countries are small for 
gestational age (1) and constitute 1/3rd of our nursery admissions. SGA babies have 
higher mortality and morbidities as compared to appropriate for gestational age 
babies (AGA). SGA babies are more prone to have asphyxia, hypothermia, pulmonary 
haemorrhage, hypotension, hypoglycemia, polycythemia, persistent pulmonary 
hypertension, acute renal failure, neutropenia and thrombocytopenia. Moreover, 
there is an increased risk of hypertension, coronary artery disease, hyperlipidemia, 
obesity and type 2 diabetes among these babies in adult life. Barker et al. were the 
first to define the correlation cardiovascular diseases in adulthood with IUGR fetuses 
and newborns (2). 
 Our clinical experience has been that a large numbers of SGA babies have 
compromised myocardial function with cardiomegaly on the chest X-ray, hypotension, 
metabolic acidosis and increased need of inotropic support. Bedside 
echocardiography in these babies has shown dilated heart with mitral and tricuspid 
regurgitation. Anticipation and early diagnosis of myocardial dysfunction before 
decompensation, judicial use of inotropic support and appropriate fluid management 
may improve the overall outcome in this group of babies.  
Though there are several trials that have evaluated cardiac function of intrauterine 
growth retarded (IUGR) babies in utero showing myocardial dysfunction in them, 
there is very limited data about cardiac function in SGA babies postnatally. 
 We planned to do a prospective observational study in SGA babies to evaluate cardiac 
functions of term and late preterm small for gestational age (SGA) babies (n=35) by 
serial echocardiographic measurements and compare this with term and late preterm 
appropriate for gestational age (AGA) babies (n=35) in the early postnatal period.  
After obtaining consent from the parents, three serial echocardiographs will be done 
at 0-8, 24-36 and 48-72 hours of age with both systolic and diastolic function 
evaluated with standard parameters. 
  
  
 
Aims and objectives: 
 
To evaluate the cardiac functions of term and late preterm small for gestational age 
(SGA) babies by serial echocardiographic measurements and compare this with term 
and late preterm appropriate for gestational age (AGA) babies during first 72 hours of 
life. 
 
  
 Review of literature 
 
• Introduction 
• Incidence 
• Classification 
• Aetiology 
• Complications 
• Hemodynamic changes   
  
 Introduction: 
The widely used term “Small for gestational age (SGA)”, was originated in the 1960s. Assuming 
that all small babies admitted in the nurseries were preterm, neonatal intensive care units 
(NICUs) were called “premature nurseries” at that time. The term“Placental insufficiency 
syndrome,” was used to describe the small babies who were born at term or post term. Prior 
to 1967, all small babies were considered preterm. It was Dr.Battaglia who had drawn 
attention to the importance of both birth weight and gestational age in determining neonatal 
morbidity and mortality.A study was published by Dr Lubchenco and colleagues at Colorado 
about distribution of birth weight / gestational age in 1963. Following this another publication 
by Battaglia FC, Dr Hellegers and Dr Frazier at Johns Hopkins in 1966 evaluated pregnancy 
outcome based on high birth weight and low gestational age. In 1967 Dr Battaglia FC and Dr 
Lubchenco LO first time came up a practical classification of newborn babies by weight and 
gestational age. They defined preterm as less than 38 weeks’, term as 38 to 42 weeks’ 
gestation, and more than 42 weeks as post term. The 10th and 90th percentiles were used to 
subdivide the birth weight into three groups.  Based on this publication newborns were 
subdivided into nine birth weight / gestational age categories. This simple way of classifying 
newborn resulted in increased recognition of SGA infants. After this, several publications 
came from other neonatal care units that described the clinical problems most frequently 
associated with SGA babies (3). 
A new born baby is classified as small for gestational age (SGA) when baby’s birth weight is 
less than 10th centile or less than 2 standards deviation for baby’s gestational age (4). 
 Small for gestational age (SGA) and fetal growth retardation (FGR) are not synonyms.SGA 
means that baby’s birth weight is less than expected (based on centile charts) irrespective of 
the etiology and regardless of the intra uterine growth velocity. In one estimation 
approximately 50–70% of fetuses born with weight < 10th centile for gestational age are 
constitutionally small. Their intra uterine growths are appropriate for size of the parent and 
their ethnicity. They usually have normal placental function and good outcome. Hence, it is 
important to distinguish FGR babies from constitutionally normal SGA babies with birth weight 
< 2nd centile (-2 standard deviation) for gestational age are more likely to have fetal growth 
restriction (5). 
Incidence: 
In developed countries approximately 10 % of term babies are SGA (6), whereas 23 percent of 
term babies are SGA in developing countries (1). SGA babies constitute approximately thirty 
per cent of admission in our nursery. 
Classification: 
SGA babies can be classified as symmetrical, asymmetrical or mixed (7). 
Symmetrical SGA babies have reduced growth of both body and head. Fetal growth 
retardation (FGR) begins early in gestation leads to symmetrical SGA and usual causes are 
intrinsic factors such as chromosomal abnormalities or congenital infections. Nutritional 
deficiency early in gestation can also restrict growth of all organs (6). 
 Asymmetric SGA have reduced body weight and relatively normal head growth. In this group 
fetal growth retardation begins in the late second or third trimesters. This result from reduced 
supply of nutrition to foetus that limits body weight but allow brain to grow (6).  
Mixed SGA: This type of SGA babies result from an insult during the second trimester, 
presenting with partial asymmetry in growth and a hypoplastic appearance. The etiologies are 
related to congenital infections (rubella, cytomegalovirus, toxoplasmosis, and others), 
medications, illicit drugs, and toxins that affect the fetus (7). 
Etiology 
 SGA may be caused by maternal, placental, or fetal factors. The mechanism responsible for 
fetal growth involves genetic, nutritional, placental and hormone factors, among others. 
Changes in these factors, as well as interference from external factors, such as the use of 
medications, drugs and infections, result in inadequate fetal growth. On several instances the 
etiologic factors overlap. 
The etiologies of SGA can be divided into maternal, fetal and placental causes.  
Maternal Factors 
Race: 
European studies have found lower birth weight across the gestational age range in 
the south Asian babies. In comparison to babes born in Europe, babies born in India 
are lighter on an average by about 600 grams.  The difference in the birth weight 
persists in the south Asian babies even if they are born in developed countries. 
Though, the difference in the birth weight reduce to approximately 300 grams (8). 
  
 
 
Maternal hypertensive disorders 
In 30% to 40% of pregnancies complicated with FGR, hypertensive disorders are 
present. The maternal vasculopathic disorders that may result in fetal growth 
restriction are pregnancy induced hypertension (PIH), chronic hypertension, 
autoimmune disorders, severe chronic nephropathy, and pregestational diabetes with 
vascular involvement (9). 
 
Preeclampsia increases the risk of having a small for gestational age babies by four 
fold (RR 4.2; 95% CI 2.2–8.0) (10).  The earlier the onset and the worse the severity of 
preeclampsia, the more severe is the FGR. In one study, the birth weight was reduced 
by 5% with mild PIH, 12% with severe PIH, and 23% with early onset disease (11). Both 
preeclampsia and FGR have underlying defective maternal placental vascular 
adaptation. 
 
The rate of FGR is higher when chronic hypertension is noted in the first trimester.  
Mild chronic hypertension in pregnancy also increases the risk of FGR. Maternal 
antihypertensive therapy does not improve fetal growth. Rather, some beta blockers 
such as atenolol increase the risk of FGR (9). 
 
Autoimmune syndromes—antiphospholipid syndrome (APS) 
 In pregnancy, autoimmune diseases with vascular involvement are related to adverse 
perinatal outcome. Incidence of stillbirths and fetal growth restriction is significantly 
higher in mothers who have antiphospholipid antibody syndrome. The risk of fetal 
death is three times higher in systematic lupus erythematosus (SLE) complicating 
pregnancy with positive antiphospholipid antibodies (APA) in comparison to negative 
APA. Polzin WJ et al in a prospective study found that APA was positive in 24% of 
foetuses with birth weight less than  the 10th centile (12). Yasuda M et al found that 
the relative risk of growth restriction was 6.2 (95% CI: 2.4–16.0) when APA was 
positive (13). 
 
Thrombophilia 
Maternal thrombophilia may lead to FGR but the evidence is not strong. Association of 
maternal thrombophilia gene polymorphism [relate to factor V Leiden, prothrombin, 
and methylene tetra hydro folate reductase (MTHFR)] with FGR is controversial. 
Several studies revealed the increased risk of FGR with thrombophilia but other did 
not. Howley HE et al in a systematic review demonstrated that the presence of factor 
V Leiden and prothrombin gene variant were significantly associated with FGR (9). 
 
Maternal Lifestyle  
FGR is associated with maternal use of various recreational agents and addictive 
substances. Several studies have shown the association of cigarette smoking, alcohol 
consumption and cocaine, methadone and heroin use with FGR (8). 
 
 Therapeutic agents 
The association of FGR with use of certain therapeutic agents in pregnancy is found in 
many studies. These medications are antineoplastic, anticonvulsants such as 
phenytoin, antihypertensive especially atenolol, and steroids.  Repeated course of 
antepartum steroids may lead to suppression of fetal somatic growth and 
neurodevelopmental problems (9). 
 
Malnutrition 
Maternal nutritional deprivation effects the fetal growth. Both pre pregnancy weight 
and weight gain during pregnancy independently affects the fetal growth. Nutritional 
intervention in mother who is nutritionally deprived before pregnancy may benefit 
the fetus but evidence is not strong. There is no additional benefit of nutritional 
supplementation to well-nourished mother (8). 
 
Others 
Many other factors related to mother can result in FGR (8).  
 Inflammatory bowel disease: by interfering with maternal nutrition. 
 Hemoglobinopathies like sickle cell anemia, cyanotic heart disease, 
chronic asthma: by interfering with fetal oxygenation 
 Uterine anomalies–large submucous myomas, septate uterus, synechia 
 Exposure to radiation, and living at high altitudes. 
 
 Fetal factors 
Genetic factor 
A wide range of chromosomal abnormalities (aneuploidy, deletion translocation) are related 
to FGR.  
Aneuploidy: Approximately ninety percentages of the fetuses with Edward syndrome are SGA 
and 30% of those with down syndrome (9). 
Uniparental disomy: a chromosomal disorder where a fetus inherits a pair of homologus 
chromosome from the same parent has been associated with FGR. Single gene disorder, 
inborn error of metabolism and non-chromosomal syndromes are associated with FGR. 
Genomic imprinting:  The consequences of abnormal imprinting are FGR and dysmorphic 
picture. Prader Willi syndrome and Silver-Russell syndrome are the classic examples of such 
disorders. 
Fetal malformation: 
 A major congenital abnormality is found in approximately 8 % of all SGA babies. 
Among babies with significant anomalies the incidence of SGA is 22 % (8). The risk of 
FGR is increased by multiple malformations.  With 2 defects the incidence of FGR is 
20%  whereas 60 % in babies with more than eight defect (9). 
Gastroschisis, omphalocele and diaphragmatic hernia are commonly associated with 
FGR. The congenital heart diseases that are associated with SGA are atrio-ventricular 
canal defect, hypoplastic left heart syndrome, tetralogy of Fallot, truncus arteriosus, 
pulmonary stenosis, and ventricular septal defect. 
 A single umbilical artery may result in FGR even in the absence of any other associated 
abnormalities (9). 
Congenital infections: 
The viral and protozoan infections in utero contribute to approximately 5% to 10% of the fetus 
with growth restriction. Cytomegalovirus is the most common infective organism that is 
associated with FGR. Other viral agents that are most often associated with FGR are rubella, 
human immunodeficiency virus, and varicella-zoster. 
The most frequent mechanism that leads to growth restriction in fetus is decrease in the cell 
population. 
Protozoan infections that can lead to FGR are malaria and toxoplasmosis. Malaria can cause 
anemia in mother, prematurity, and FGR. 
Bacterial infections usually do not cause growth restriction of fetus. Subclinical infection and 
inflammation as demonstrated by histologic chorioamnionitis may result in fetal growth 
restriction. In addition, extragenital infection may also lead to FGR. The recent studies found 
that periodontal disease in mother may result in prematurity and growth restriction (14). 
Multiple gestation 
Multiple gestation poses challenge to the maternal system to deliver an ideal environment for 
fetal nourishment. Growth of the individual fetuses in multiple pregnancies follow a different 
trajectory than that observed in singleton fetuses. Until 30 to 32 weeks of gestational age, 
growth curves of twin and singleton fetuses follow the same growth curve beyond which the 
growth is delayed in twins than singletons. The more the number of fetuses, the earlier the 
 growth deceleration starts. Approximately, twenty percent of the dichorionic twins and thirty 
percent of the monochorionic twins are SGA at birth. Etiologic factors are similar to those 
described in the singletons with an additional effect of discordancy (9). 
Placental factors: 
Placenta is the lifeline between the mother and the fetus to supply. Umbilical blood and 
utero-placental circulation normally supply both nutritional substrates and oxygen to the 
fetus and remove carbon dioxide and waste products of fetal metabolism from the fetus. 
Placenta plays a crucial role in growth of fetus and its dysfunction leads to FGR. Placental 
abnormalities that can result in FGR are: 
 Confined placental mosaic 
 Placenta previa 
 Abruptio placentae 
 Infarction 
 Circumvallate placenta 
 Placenta accreta 
 Hemangioma 
Inadequate placentation accounts for approximately 25 to 30 % cases FGR (7). 
  
 Fetal adaptation to placental insufficiency 
Advancement of Doppler technology has helped us to know the blood flow in many fetal 
vessels for example, umbilical arteries, aorta, mesenteric arteries, renal arteries, and cerebral 
arteries. Increase in umbilical artery resistance and redistribution of blood flow in different 
fetal vessels happens in the growth restricted fetus. Increase resistance in umbilical artery 
blood flow is associated with reduced numbers of small arteries in tertiary villous (15).  Fetal 
adaptation to placental insufficiency helps to maintain blood flow to the vital organ. With 
persistently compromised placental blood flow adaptive mechanism fails which leads to 
higher resistance in umbilical vessels and lower resistance in the cerebral vessels vascular 
resistance (‘ brain-sparing effect’).  
With further deterioration, fetal starts to decompensate under the stress of hypoxia and 
develops hypoglycemia, acidosis, thrombocytopenia, and oliguria (16). Before the death of the 
fetus, there is a loss vasodilatation in cerebral vessels which either results from changing 
vascular sensitivity to decreased oxygen concentration or from a decrease in cardiac output of 
fetus.  
The fetus has very low oxygen tension [Partial pressure of oxygen (PaO2) of 25 mm Hg] in 
utero. Hence it is important to maintain an adequate uptake of oxygen.  The following two 
factors help the fetus to transport large amounts of oxygen from the placenta and supply it to 
different organs: 
 A higher affinity of fetal haemoglobin to oxygen  
 Higher rate of perfusion to fetal organs in comparison to oxygen requirements. 
 Any factor that interrupts the maternal uteroplacental circulation can cause decreased oxygen 
delivery to fetus. Likewise, any maternal condition for example, preeclampsia superimposed 
on chronic hypertension that leads to long-standing compromise in maternal uteroplacental 
circulation, not only causes hypoxia in the fetus, but also leads to decrease glucose delivery 
and fetal glycogen stores. To adapt to hypoxia and hypoglycemia, the fetus starts conserving 
energy. The following   sequence of events is seen in fetus: 
 decrease or cessation of growth of fetus 
 decrease in activity of fetus 
 redistribution of cardiac output to vital organs (brain, heart, and adrenal glands) 
 increase in extramedullary hematopoeisis resulting in polcythemia 
 increased gluconeogenesis in fetal liver and  
 development of metabolic acidosis because of anaerobic metabolism of glucose 
 fetal growth retardataion (7). 
  
 Complications of SGA babies: 
I. Prematurity and related complications 
II. Perinatal asphyxia 
III. Hypothermia 
IV. Hypoglycemia 
V. Hypocalcemia 
VI. Polycythemia 
VII. Compromised immune function and sepsis 
VIII. Coagulopathy 
IX. Pulmonary haemorrhage 
X. Hepatocellular dysfunction 
XI. Meconium aspiration syndrome. 
  
  
Short-term complications: 
PREMATURITY AND RELATED COMPLICATIONS 
There is higher risk of prematurity and prematurity related complications in growth-restricted 
babies. In comparison to term, higher incidence of SGA is found in the babies who are born 
preterm (17). The published data are contradictory, but recent evidence has shown an 
increased incidence of prematurity related complications SGA babies in comparison to AGA 
babies, that include respiratory distress syndrome and chronic lung disease  (18,19). 
Probable explanation of increased risk of respiratory related morbidities in preterm infants 
could be the followings:  
 delay in metabolic adaptation as result of intrauterine hypoxia,   
 systemic inflammatory responses,  
 postnatal reperfusion injury and  
 increased level of oxygen-free radicals (20). 
 
There is increased incidence of necrotizing enterocolitis (NEC) in SGA babies (19). As an 
adaptive response to compromised oxygen delivery blood supply in SGA foetus is maintained 
to the vital organ at the expense of mesentery and renal blood supply. Abnormal Doppler in 
the form of absent end diastolic flow or reversed diastolic flow on antenatal scan is found to 
be at higher risk of developing NEC (21). 
 
The incidence of grade 3 and 4 intraventricular haemorrhage is also found to be higher in the 
preterm SGA babies in comparison to the AGA preterm babies (22). 
  
PERINATAL ASPHYXIA 
SGA babies have limited carbohydrate reserve and are have marginal oxygenation in utero. 
This makes them more prone to hypoxic ischemic injury when they go through the stress of 
labour and delivery. 
SGA babies have increased incidence of low Apgar scores, umbilical pH, and need of 
resuscitation in the delivery room. The incidence of hypoxic ischemic encephalopathy, 
seizures and perinatal stroke is also increased (22). 
 
HYPOTHERMIA 
SGA babies are more vulnerable to develop hypothermia because of a higher brain weight to 
body surface area ratio, impaired supply of glucose, diminished insulating fat and 
compromised lipid metabolism. The brown fat store is depleted in some of these babies. In 
comparison to AGA babies SGA infants have narrow thermoneutral environmental 
temperature (8).  If challenged to low environmental temperature, they maintain normal body 
temperature by increasing basal metabolic rate, which may lead to acidosis, hypoglycemia and 
poor growth (22). 
 
HYPOGLYCEMIA 
The SGA babies are at increased risk of hypoglycemia during the initial 72 hours of life (8). In 
approximately 9 % of SGA infant, hypoglycaemia during fast could be prolonged and continue 
even after establishing adequate intake of carbohydrate. The following factors make them 
unable to maintain euglycemic state:  
 Inadequate glycogen and adipose stores,  
  Hyperinsulinemia and an altered insulin : glucagon ratio, 
 Impaired gluconeogenesis and ketogenesis. 
 Increased consumption because of hypothermia, asphyxia or polycythaemia 
(22). 
For those infants requiring intravenous dextrose immediately after birth, screening later 
during hospitalization while transitioning to a fasting enteral feeding regimen may identify 
infants at risk for prolonged hypoglycemia. 
 
HYPOCALCEMIA 
Hypocalcemia is not seen commonly in SGA babies but have been reported (23). In the 
presence of prematurity and asphyxia these babies are at higher risk of hypocalcemia.  
 
POLYCYTHEMIA 
Polycythemia, defined as central venous haematocrit > 65%, occurs in approximately forty 
percent   of late preterm and term SGA infants (8). Chronic intrauterine hypoxia as a result of 
placental dysfunction leads to increase in erythropoietin production which causes increased 
red cell mass. Polycythemia predisposes these infants to hypoglycemia, hyperbilirubinemia, 
NEC, cardiopulmonary and neurological dysfunction (24). 
 
IMMUNE FUNCTION AND SEPSIS 
SGA babies are at higher risk of developing sepsis because of compromised immune system. 
Growth restricted babies have a decrease in IgG concentration, phagocytic index, and 
lysozymes. Deficient lymphocyte function, neutropenia and thrombocytopenia are seen in 
some of these babies (22). 
  
COAGULOPATHY 
SGA babies have reduced level of vitamin K-dependent coagulation factors and low platelet 
count. Low vitamin K-dependent coagulation factors may be due to decrease production of 
these factors by liver secondary to in utero hypoxic injury. Thrombocytopenia and decreased 
vitamin K-dependent coagulation factors predispose the SGA babies to develop coagulopathy.   
 
PULMONARY HEMORRHAGE: 
Massive pulmonary haemorrhage has been reported as a cause of sudden unexpected death 
in infants with severe growth restriction (25). 
 
HEPATOCELLULAR DYSFUNCTION 
There have been concerns of hepatocellular dysfunction in growth restricted babies. Preterm 
SGA babies are more likely to develop TPN associated cholestasis than AGA babies who are 
less mature (22). 
  
 Long term complications 
In the first year of life most of the SGA babies show some catch-up growth. In 
comparison to AGA babies, SGA babies remain somewhat shorter and have smaller 
head circumference. Approximately 29% of term and 44 % of preterm SGA babies 
remain below the 5th percentile. Some of the SGA babies do not have catch-up growth 
and about 50 % of them short. The symmetry in SGA infants is not a good predictor of 
growth in early childhood (8). 
FGR is associated with higher incidence of behavioural problem, cognitive 
development and cerebral palsy. Neonates with poor head growth are at the highest 
risk of poor neurodevelopmental outcome.Cognitive impairment was also seen in 
neonates with appropriate head growth (8). 
Growth restricted babies are found to be at higher risk of hypertension, coronary 
artery disease, hyperlipidemia, obesity and type 2 diabetes in their adulthood. Barker 
et al. were the first to describe ‘fetal programing’ of the adult disease. They 
demonstrated the etiopathogenic correlation between cardiovascular diseases in 
adulthood and disorders observed in growth restricted fetuses/newborns (2). 
Several epidemiologic, clinical, and animal studies have demonstrated the influence of 
intrauterine environment on fetal growth and development and the subsequent 
development of adult diseases. During development there are critical specific 
windows which often coincide with phase of rapid cell division. The insult during these 
specific windows may have long-lasting consequences on functioning of tissue or 
organ in postnatal life (26).  
  
Hemodynamics derangement in SGA babies: 
Recent studies have shown compromised cardiac function in SGA infants.The 
physiological explanation for this may be because a large number of SGA babies have 
placental insufficiency. Hence, they are chronically hypoxic and nutritionally deficient.  
This together with an increased placental vascular resistance result in a combined 
pressure and possibly volume overload of the fetal heart, which induces abnormal cardiac 
function (27). 
Crispi et al found in their study that growth restricted foetus had signs of compromised 
cardiac function from early stage of the fetal compromise. They also found that cardiac 
function of these foetuses deteriorate further with compromising fetal status. 
Biochemical evidence of cell damage also evolved with the progression of fetal 
compromise.  They studied 81 AGA and 81 IUGR foetuses that were classified in 3 
different stages based on diastolic flow of umbilical artery. Stage 1, 2 and 3 were 
classified as normal, absent and reversed diastolic flow respectively. In comparison to 
AGA, growth restricted foetuses had higher modified-myocardial performance index, 
blood B-type natriuretic peptide (BNP), and early-to-late diastolic filling ratios, in a stage-
dependent manner. In comparison to control fetuses, IUGR fetuses  had increased  level 
of heart fatty acid– binding protein at stage 3 (28). 
 
Comas et al had evaluated cardiac function of 58 SGA and 58 gestational-age matched 
AGA fetuses using conventional echocardiography. Echocardiographic parameters used to 
 assess cardiac function were E/A ratio, MPI by conventional echocardiography and 
annular peak velocities and MPI’ by, tissue doppler imaging. They had found that in 
comparison to controls, growth restricted fetuses had a nonsignificant trend to increased 
left MPI and E/A ratios. With TDI, SGA foetuses had significantly higher MPI values and 
lower right E’ and A’ peak velocities. Their findings also supported that growth restricted 
foetuses have subclinical cardiac dysfunction (29). 
 
Cruz-Martinez RO et al had shown cardiovascular doppler abnormalities in a proportion 
of SGA foetuses. They had evaluated the cardiac function of term SGA foetuses that had 
normal umbilical artery (UA) doppler. They had measured MPI, pulsatility indices (PI) of 
aortic isthumus (AoI) and ductus venosus (DV) within 1 week prior to delivery in SGA 
fetuses with normal UA Doppler (n=178) and  compared that with 178 AGA foetuses 
matched by gestational age. SGA fetuses had significantly higher MPI and AoI PI and 
similar DV PI as compared to controls. They had found that 7.3 % of SGA had retrograde 
net blood flow in the AoI (30). 
 
Girsen A et al in the prospective cross-sectional study, has assessed the human fetal N 
terminal peptide of pro B-type natriuretic peptide (NTpro BNP) in umbilical arterial blood 
sample of 42 growth restricted foetuses who had hemodynamic assessment by doppler 
ultrasonography within a week before delivery and compared with 49 neonates with 
uncomplicated pregnancy and delivery.  Cases were divided into 3 groups based on the 
abnormality in UA and DV velocimetry.  
  Group 1: normal UA velocimetry (n=13).  
 Group 2: abnormal UA and normal DV velocimetry (n = 15) and  
 Group 3: abnormal UA and DV velocimetries (n = 14). 
There were no differences in ventricular ejection forces and weight-indexed cardiac 
outputs among the groups. The level of NT-proBNP was significantly increased in group 3 
fetuses than fetuses in Groups 1 and 2. They found a significantly positive correlation 
between NT-proBNP concentrations and velocimetries of UA and DV (31). 
 
T.D Metz et al in their study have found that SGA babies had greater need for vasopressor 
support during the first week of life despite similar BP parameters as compared to AGA 
babies. In a retrospective case–control matched study, they evaluated the hemodynamic 
parameters of 24 SGA and 48 AGA babies (matched for gestational age) during the first 7 
days of life and the week prior to discharge. Blood pressure parameters did not differ 
during the first 7 days of life. At birth, heart rate was significantly lower in SGA neonates 
as compared to AGA neonates (148.2 ± 19.2 vs. 159.2 ± 17.1, p < 0.001). There were 
greater need for vasopressor support among SGA neonates (OR 5.66; 95% CI 2.28, 14.04) 
than controls. Prior to discharge systolic BP was lower in SGA newborns (32). 
 
Leipälä JA et al had recruited 3I SGA and 32 AGA babies in the study to explain 
hemodynamic changes in growth restricted very low birth weight (<1500 g) babies. They 
found elevated serum brain natriuretic peptide (BNP) and increased diastolic diameters of 
the left ventricle and the interventricular septum in SGA neonates. Initially, LV CO was 
 higher in the SGA than the AGA babies (243 ± 47 versus 150 ±  28 mL/kg/min, p < 0.05). 
During the study period LV CO increased gradually in the AGA group (LVO was increased 
by 39% on day 3 and by 89% in the end of the study), but LV CO did not increase in the 
SGA neonates. Both IVSD and LVEDD had significant correlation with serum BNP. Serum 
BNP was 48 ± 53 pmol/L in SGA infants and 27 ± 13 pmol/L in the AGA (p < 0.05). Their 
findings were suggestive of increase in cardiac workload after intrauterine growth 
retardation (33). 
 
A study by Altin et al looked at myocardial function of term small for gestational age 
babies with mild IUGR. At 72 hours echocardiograph showed that SGA babies had higher 
values for left ventricular end diastolic diameter index (LVEDDI), pulsed wave Doppler 
MPI, and tissue Doppler imaging MPI as compare to the control group (27). 
 
Sehgal A et al has investigated the differences in cardiac function and arterial biophysical 
properties between term AGA neonates and SGA neonates in a recent prospective 
observational study. Echocardiographic evaluation was performed at 2-5 postnatal days 
on 20 term SGA and 20 term AGA neonates. As compared to control, SGA babies had 
significantly higher blood pressure. SGA neonates had lower LV CO (170 ± 31 mL/kg/min 
vs 197 ± 39 mL/kg/min). SGA neonates had reduced E and A wave velocities and higher 
E/A ratio and isovolumic relaxation time was prolonged. SGA neonates had significantly 
greater aortic intima-media thickness, arterial wall stiffness index and input impedance. It 
 was concluded that SGA neonates had altered cardiac function and arterial biophysical 
properties (34). 
The postulated mechanism for the cardiac dysfunction is as follows: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chronic hypoxia 
Abnormal cardiac function 
Pressure and volume overload 
Increase in placental 
vascular resistance 
Nutritional deficiency 
 Most of the trials have evaluated the cardiac function of intrauterine growth retarded 
(IUGR) fetuses and have found that they had myocardial dysfunction. But, there is limited 
data about cardiac function in SGA babies in immediate postnatal age.  The evaluation of 
cardiac function of these babies in the immediate postnatal period will help guide 
management of these babies. 
 METHODOLOGY 
Type of study: Prospective observational study 
Setting: Department of Neonatology, Christian Medical College, Vellore from March 
2013 to Feb 2014 
Participants:  
Eligibility criteria: 
Study group:  
Baby born in CMCH at term and late preterm gestation (between 34 and 41 weeks of 
gestation) with birth weight < 2 Standard deviation (around 3rd centile) as per WHO 
growth chart (FENTON)(35).Gestation age was decided based on first trimester 
ultrasound scan or Dubowitz score if first trimester scan was not available.  
Comparison group: 
Baby born in CMCH at term and late preterm gestation (between 34 and 41 weeks of 
gestation) with birth weight between 10th to 89th centile (matched for gestational 
age, one control for every case, who will remain in the hospital for 48 to 72 hours eg: 
Babies who are delivered by LSCS/who are at risk of hyperbilirubinemia because of Rh 
or ABO incompatablity, maternal illness etc). 
 
 Exclusion criteria: 
Outborn babies 
Refusal of consent 
Acute Perinatal asphyxia 
Baby with major congenital anomalies(eg, CDH, TEF, etc)  
Congenital heart disease 
Infant of diabetic mother 
Maternal chorioamnionitis 
Anemia 
Assessment of cardiac function: 
Three consecutive echocardiography were performed for all the babies who fulfil the 
eligibility criteria: 
 1ST = 0-8 hours 
 2nd = 24-36 hours 
 3rd = 48-72 hours 
All images were stored. We have checked the following parameters of cardiac function 
for all the babies: 
 
 
 Myocardial performance index:  
In 1996, myocardial performance index (MPI also known as the Tei index) was 
formulated and published by TeiChuwa that evaluates both systolic and diastolic 
function of the heart. MPI has been proved to be a reliable method for the evaluation 
of systolic and diastolic performance of left ventricle.   
MPI = IVCT + IVRT / ET  
[includes the isovolumic contraction time (IVCT), the ejection time (ET) and the 
isovolumic relaxation time (IVRT)] . 
 
MPI was calculated from the ratio of time intervals (a-b/b) derived with the help of 
PWD (Figure). In the apical 4-chamber view, mitral valve closing to opening time (a) 
was measured from the doppler waveform with the help of PWD at the tips of the 
 mitral valve leaflets. The PWD cursor was then moved to the LV outflow tract, just 
below the aortic valve in apical 5-chamber view for the measurement of the LV 
ejection time(b).  
For the MPI of the right ventricular the tricuspid valve closing to opening time (a) was 
measured in the apical 4-chamber view with the PWD cursor placed between the tips 
of the tricuspid valve leaflets. The right ventricular ejection time (b) was obtained 
from the parasternal long-axis view, with the PWD cursor located just below the 
pulmonary valve. 
The followings are the advantages of using MPI for evaluation of cardiac function: 
• It is easy to measure and a non-invasive method. 
• It does not necessitate the presence of an echocardiographer with 
great experience.  
• MPI is a ratio of time intervals. Hence, the calculation of the index is 
not dependent of ventricular volume measurement.  
• Blood pressure and heart rate do not affect the MPI.  
• In many different clinical settings, it appears to be of great prognostic 
value (36). 
Fractional shortening (FS): It is one of the most commonly used measurements of left 
ventricular function in newborn babies with very good reproducibility. It is calculated 
as  
FS (%) = (LVIDD – LVIDS)/LVIDD     x     100 %     
 ( includes LVIDD: left ventricle internal diameter during diastole, LVIDS: left ventricle 
internal diameter during systole) 
We measured FS in parasternal long axis by using M-mode just distal to mitral valve 
leaflet tip. The normal range in term babies is 25-41% and in preterm babies is 23-40% 
(37). 
Area Shortening (AS) : Lee et al noticed studies that during the early postnatal days 
(first 7 to 10 days) the inter ventricular septum contractility was relatively lesser than 
other walls of the left ventricle. Area shortening measures the movement of all the 
wall of left ventricle. Hence AS is a more robust method of assessment of myocardial 
function. It was measured in low parasternal short axis view at the level of tip of the 
mitral valve.  
Area shortening = (End diastolic area – End systolic are) / End diastolic area X 100 % 
Normal value = 45 to 65% (38). 
Ejection fraction(EF):  
EF =  stroke volume/end-diastolic volume 
Thus, 
EF = (LVEDD3 – LVESD3)/LVEDD3 X 100 % 
We measured EF in long axis parasternal view by using M-mode just distal to mitral 
valve leaflet tip.  
 
 Left ventricular output (LVO): 
LVO is measured in ml/kg/min = stroke volume X heart rate/ body weight (kg) 
Stroke volume: Ascending aorta velocity time integral (VTI) X (Pi X ascending aortic  
Diameter2 /4) 
Ascending aorta internal diameter was measured just beyond the coronary sinus in 
mid-systole in the parasternal long axis view using 2D mode. 
Ascending aorta velocity time integral (VTI): We used apical long axis view to measure 
the VTI with pulsed wave Doppler (PWD). The advantages of using this view are:  
• The angle of insonation can be seen  
• The measurements can be performed without causing much discomfort 
to the baby.  
We tried to minimise angle of insonation and did not use angle correction for the 
measurements. 
Normal LVO (ml/kg/min): Term babies = 236 +_ 47, preterm babies = 221+_56 (37). 
In the early postnatal period with ductal patency, LVO is sum of systemic blood flow 
and left to right flow through PDA. 
Right ventricular output (RVO):  
RVO is measured in ml/kg/min = stroke volume X heart rate/ body weight (kg) 
 Stroke volume: Main pulmonary artery VTI X (Pi X main pulmonary artery diameter2 
/4) 
Main pulmonary artery internal diameter was measured at the level of insertion of the 
valve leaflet in mid-systole in the short axis parasternal view using 2d mode. 
Main pulmonary artery VTI:  Low parasternal pulmonary artery long axis view using 
PWD. 
Normal RVO (ml/kg/min) = 150 to 300  
E:A ratio: 
It was measured in apical four chamber view using PWD. The findings in newborn are 
quite different from those in adult. In newborn babies, the tricuspid E wave is typically 
of lower velocity than the A wave. So E:A peak velocity ratio is on average 0.8:1. 
The mitral E wave is typically slightly higher than the A wave. The average E:A ratio is 
between 1.1:1 to 1.2 :1 over the first few days (37). 
Left atrium/Aortic ratio (LA: AO) : 
This ratio was measured in long axis view using M mode. The M mode cursor is 
dropped through the aortic cusps into the left atrium. Diameter of LA is measured at 
the point of maximal forward excursion of the aorta.  
Superior vena cava (SVC) flow:  
SVC flow is measured in ml/kg/min = stroke volume X heart rate/ body weight (kg) 
Stroke volume: SVC VTI X (Pi X mean SVC diameter2 /4) 
 Mean SVC diameter: We have measured this with M-mode in left mid parasternal 
window. We have taken the average of maximum and minimum diameter. 
SVC VTI: it was measured in low subcostal view using PWD. 
Normal Values in preterm babies = 45 to 120 ml/kg/min (39). 
Tissue Doppler imaging (TDI):  
The images had been recorded at the apical 4-chamber view from the LV lateral mitral 
and tricuspid annulus and basal portion of IVS. 
Isovolumic contraction time (IVCT), isovolumic relaxation time (IVRT), and myocardial 
ejection time were measured by TDI.  
The tissue Doppler imaging (TDI) MPI was calculated using the following formula:  
                                             (IVCT+IVRT)/Ejection time 
 TDI assessment of diastolic function is less load dependent than that provided by 
standard Doppler techniques (40). 
E/E1: Simultaneous cardiac catheterization and echocardiographic studies have shown 
that LV filling pressures are correlated with the ratio of the mitral inflow E wave to the 
tissue Doppler Ea wave (E/E1). This relation is based on Ea velocities that “correct” E-
wave velocities for the impact of relaxation  (40). 
Measurement of peak systolic velocity (PSV), end diastolic velocity (EDV), resistive 
(RI) and pulsatility (PI)  in the peripheral arteries: coeliac artery, superior mesenteric 
artery and anterior cerebral arteries. 
 Coeliac artery: Measurements were performed in the sagittal plane just at the origin 
from aorta.  
Superior mesenteric artery: Measurements were performed in the transverse plane, 
on a straight segment, near to its origin from abdominal aorta. 
Anterior cerebral artery: measurements were performed in the sagittal plane through 
the anterior fontanelle in front of the genue of corpus collasum using curve linear 
probe. 
Sample size: 
The sample size was to show a difference in left ventricle Myocardial Performance 
Index (MPI) across SGA and AGA infants was found to be 35 infants in each group with 
80% power and 5% level of significance when the difference in MPI was expected to 
be 0.041 (7) and a variation of 0.06 units across the infants in both the groups.    
This number was considered for late preterm and term babies. In total, the sample 
size will be 35 for AGA and SGA babies . 
Statistical methods: 
The analyses were done separately for AGA babies and SGA babies.  
All the quantitative variables were summarized using mean and standard deviations 
for parametric data and median and maximum minimum values for non parametric 
data. All categorical variables were summarized using frequencies and percentages. 
Depending upon distribution of the continuous variable Student’s t test or Mann–
Whitney U test were used for determining significance. We used Chi-squared test or 
 Fisher’s exact test for categorical variables. P value < 0.05 was considered as 
significant. 
 Results 
 
Thirty five term and late preterm were enrolled in each SGA and AGA group. Babies 
whose birth weight was less than 3rd percentile, were included in SGA group and those 
with birth weight between 10th and 90th percentile, were recruited as AGA baby. The 
functional echocardiography was performed on first 3 consecutive days on all the 
babies. Echocardiography was performed at the mean time of 5 ( ±  1), 31 ( ± 3) and 59 
( ± 7) hours of life.  
 
In all the tables, data were shown as mean (± standard deviation) for normally 
distributed data and median (minimum–maximum) for  non parametric data.  
 
Echocardiography performed at mean time of 5, 31 and 59 hours was represented as 
1, 2 and 3 respectively in all the tables. 
  
 Table 1 
Demographic and clinical findings of study population 
 AGA (N=35) SGA (N=35) 
Gestational age (weeks) 36 (34-39) 36 (34-39) 
Sex                            Boy 
Girl  
17 
18 
17 
18 
Birth weight (gms)* 2600 
(1950-3400) 
1700 
(1200-1960) 
Length (cm)* 46.4 (± 2.3) 42.1 (± 2.2) 
Head circumference 
(cm)* 
33 (±1.7) 30.7 (±1.8 ) 
Body surface area (m2)* 0.18 (0.15-0.22) 0.14 ( 0.12-0.15) 
Ponderal index * 2.57(±0.24) 2.24 (±0.27) 
Mode of delivery 
Normal 
LSCS 
Forcep 
Vaccum 
 
13 
18 
3 
1 
 
8 
24 
3 
0 
Apgar                            1 
10 
9 (5-9) 
10 (9-10) 
9 (3-9) 
10 (8-10) 
MATERNAL 
COMPLIACTIONS 
  
Parity      
primipara 
                multipara 
 
17 
18 
 
19 
16 
PIH* 5 14 
Heart disease 1 1 
Anemia 11 7 
 MSAF 1 1 
Doppler Study UA 
 
Normal 
Abnormal* 
Not done 
 
 
32 
0 
3 
 
 
23 
8 
4 
Oligohydraminos*  0 6 
Risk of sepsis 6 3 
NOENATAL 
COMPLICATIONS 
  
Hypoglycemia* 0 9 
Polycythemia 0 5 
Hyperbilirubinemia* 1 21 
Feed intolerance* 0 7 
Data were shown as mean (± standard deviation) for normally distributed data and median (minimum–
maximum) for  non parametric data. 
* P value <0.05 
As seen in the table median gestational age in both the groups were 36 weeks with a 
range of 34-39 weeks. There were 17 boys and 18 girl babies in each group. Birth 
weight, length, body surface area and head circumference were significantly lower in 
SGA group. Median value of APGAR score was similar in both the groups. PIH was the 
most common maternal medical problem in SGA group (40%). About 23% of the SGA 
babies had abnormal doppler. In the SGA group 6 babies had hypoglycemia, 5 babies 
had polycythemia, 21 had hyperbilirubinemia and 7 babies developed feed 
intolerance.  
 Table  2 
Index of myocardiac performance 
Parameters AGA MEAN (SD) SGA MEAN (SD) SIGNIFICANCE 
LIMP PWD 1 0.28 (0.17 – 0.4) 0.37 (0.19 – 0.57) 0.001 
2 0.31 (±0.35) 0.39 (±0.078) <0.001 
3 0.31 (±0.063) 0.37 (±0.056) <0.001 
LIMP TDI Septal 1 0.33 (±0.042) 0.37 ( ±0.071) 0.018 
2 0.34 (±0.042) 0.37 (±0.056) 0.024 
3 0.35 (±0.041) 0.39 (±0.062) 0.001 
LIMP TDI lateral 1 0.32 (±0.041) 0.36 ( ±0.049) <0.001 
2 0.33 (±0.036) 0.36 (±0.049) 0.004 
3 0.33 (±0.045) 0.36 (±0.058) 0.039 
RIMP PWD 1 0.35(±0.075) 0.40 (±0.071) 0.007 
2  0.26 (±0.50) 0.34 (±0.71) <0.001 
3 0.26 (0.18 – 0.43) 0.30 (0.19 – 0.43) 0.061 
RIMP TDI 1 0.32 (0.23-0.42) 0.34 (0.27–0.49) 0.032 
2 0.33 (±0.048) 0.37 (±0.072) 0.038 
3 0.32 (±0.046) 0.36 (±0.072) 0.015 
Data were shown as mean (± standard deviation) for normally distributed data and median (minimum–
maximum) for  non parametric data. 
LIMP: Left ventricle index of myocardial performance, RIMP: right ventricle index of myocardial 
performance, PWD: Pulsed wave doppler, TDI: Tissue doppler imaging 
 
Table no 3 illustrates higher value of myocardial performance index (measured by 
pulsed wave doppler and tissue doppler imaging) in both the ventricles in the SGA 
 group than AGA group. This difference was statistically significant for all the values 
except RIMP PWD on day 3. 
Table 3 
Ventricular ejection time 
Parameters AGA MEAN 
(N=35) 
SGA MEAN 
(N=35) 
SIGNIFICANCE 
LVET PWD (ms) 1 209 (±13.6) 185 (±13.3) <0.001 
2 204 (±13.7) 186 (±10.4) <0.001 
3 199 (±15.8) 1823 (±13.3) <0.001 
LVET TDI Septal (ms) 1 224 (±17) 202 (±16.5) <0.001 
2 222 (181 – 326) 205 (172 – 250) 0.04 
3 213 (±13) 198 (±16.7) <0.001 
AVET TVI Lateral (ms) 
1 
227 (±18.2) 203 (±14.5) <0.001 
2 223 (±13.2) 210 (±13.2) <0.001 
3 215 (±15.9) 202 (±14.5) <0.001 
RVET PWD (ms)  1 218 (±121.5) 188 (±17.1) <0.001 
2 223 (±19.5) 200(±13.9) <0.001 
3 215 (±12.7) 19.9 (±12.3) <0.001 
RVET TDI (ms) 1 222 (192-277) 203 (177 – 244) <0.001 
2 222 (±17.7) 207 (±14.7) <0.001 
3 218 (±16.6) 201 (±14.7)  <0.001 
Data were shown as mean (± standard deviation) for normally distributed data and median (minimum–
maximum) for  non parametric data. 
 LVET: left ventricle ejection time, RVET: right ventricle ejection time, PWD: Pulsed wave doppler, TDI: 
Tissue doppler imaging 
Table 3 shows that both left and right ventricle ejection time were significantly 
reduced in SGA group in comparison to AGA group.  
Table 4 
Hemodynamic parameter 
Parameters AGA SGA Significance 
Heart rate 1 126 (±12) 141 (±10) < 0.001 
2 128 (±13) 136 (±12) 0.007 
3  130 (±11) 139 (±12) 0.003 
Systolic BP(mm Hg)  1 58 (±6) 55 (±5) 0.126 
2 59 (±7) 57 (±6) 0.201 
3  60 (49-84) 68 (40-79) 0.154 
Diastolic BP(mm Hg) 
1 
35 (27-46) 34 (25-52) 0.758 
2 37 (±5) 37 (±6) 0.926 
3 37 (±6) 36 (±6) 0.267 
Mean BP(mm Hg) 1 44 (±5) 43 (±6) 0.554 
2 45 (39-59) 44 (38-57) 0.282 
3  46 (38-64) 44 (38-58) 0.170 
 BP: blood pressure 
SGA babies had significantly increased heart rate than AGA babies in all the analysis. 
No difference was found in Systolic, diastolic and mean blood pressure between the 
two groups. 
 
Figure 1 
 
Figure  1 showed higher heart rate in SGA babies than AGA babies in first 3 days of postnatal 
life.  
 Table 5 
Ventricular relaxation and contraction time 
Parameters AGA  SGA  SIGNIFICANCE 
MV IVRT (ms) 1 39 (28 – 55) 39 (28-55) 0.147 
2 44 (33 - 50)  44 (28 – 61) 0.147 
3 44 (30 – 55) 44 (39 – 61) 0.565 
MV IVCT (ms) 1 33 (22 - 44) 28 (22 – 39) 0.384 
2 33 (22 - 44) 33 (22 – 39) 0.626 
3  33 (22 - 44) 28 (22 – 39) 0.722 
TV IVCT (ms)  1 28 ( 22-50) 28 (18-44) 0.870 
2 28 (22 – 39) 28 (22 – 55) 0.876 
3 28 (26 – 41) 28 (18 – 39) 0.446 
TV IVRT(ms)  1 44 (26 – 61) 41 (28 – 67) 0.850 
2 44 (33 – 61) 50 (26 – 78) 0.259 
3 39 (30 – 55)  44 (30 – 61)  0.589 
Data were shown as mean (± standard deviation) for normally distributed data and median (minimum–
maximum) for  non parametric data. 
MV: Mitral valve, TV: Tricuspid valve, IVRT: Isovolumic relaxation time, IVCT: Isovolumic contraction 
time 
As pictured in table no 5, there were no difference in Isovolumic relaxation time and 
Isovolumic contraction time between the two groups.  
 Table 6 
Outflow tract diameter and area shortening 
Parameters AGA MEAN 
(N=35) 
SGA MEAN  
(N=35) 
P value 
LVOT Diameter(mm) 1 6.3(± 0.56) 5.6(± 0.5) <0.001 
2 6.3(± 0.59) 5.6(± 0.49) <0.001 
3 6.2(± 0.59) 5.6(± 0.52) <0.001 
RVOT diameter (mm) 
1 
7.2(5.7-9) 6.5(5.6-8) <0.001 
2 7.1(± 0.8) 6.3(± 0.72) <0.001 
3 6.8(5.8-8.7) 6.3(4.6-7.2) <0.001 
Max area(cm2) 1 2.9(2-4) 2.4(1.8-3.2) <0.001 
2 2.9(2.2-3.9) 2.2(1.8-3) <0.001 
3 2.7(1.9-4.2) 2.3(1.7-3.1) <0.001 
Min area (cm2)1 1.6(1-3.3) 1.4(1-2) <0.001 
2 1.6 (1.1-2.4) 1.3(0.9-1.8) <0.001 
3 1.5(± 0.28) 1.3(± 0.2) 0.001 
Area shortening(%) 1 44.4(± 6) 43.4(± 6.2) 0.509 
2 45(± 5.4) 43.6(± 5.8) 0.279 
3 46.1(± 5.8) 44.5(± 6) 0.272 
Data were shown as mean (± standard deviation) for normally distributed data and median (minimum–
maximum) for  non parametric data. 
LVOT: left ventricle outflow tract, RVOT: right ventricle outflow tract. 
This table illustrates that both left and right ventricles outflow tract diameters were 
significantly lower in the SGA neonates than AGA neonates. Similarly, maximum and 
minimum area that was measured in the short axis view, were significantly decreased 
 in SGA babies in comparison to AGA babies. However, area shortening in both the 
groups was similar.   
Table 7 
M mode measurements : cardiac dimension, fractional 
shortening and ejection fraction 
Parameters AGA MEAN (N=35) SGA MEAN (N=35) SIGNIFICA
NCE 
LVIDD(mm) 1 16.3 (13.8-21) 15.2 (13.2-19.2) 0.005 
2 16.5 (±1.6) 15 (±1.53) <0.001 
3 16.3 (±1.42) 14.9 (±1.21) <0.001 
LVIDD INDEX (mm/m2) 1  91.3 (70-112) 112.8 (87-129.9) <0.001 
2 90.8 (±8.64) 108 (±9.56) <0.001 
3 88.6 (79.3-112.7) 106.8 (88.5-128.9) <0.001 
LVIDS(mm) 1 11.3 (±1.54) 10.5 (±1.28) 0.023 
2 11.1 (±1.127) 10.3 (±1.33) 0.012 
3 11.0 (±1.13) 10.4 (±1.02) 0.014 
LVIDS INDEX (mm/m2) 1 61.9 (±6.7) 76.1(±9.6) <0.001 
2 60.8 (±7.4) 74 (±8.7) <0.001 
3 60.3 (±5.9) 74.8 (±7.7) <0.001 
FS(%) 1 32.0 (15-41) 31.0 (21-41) 0.548 
2 33.2 (±4.18) 31.5 (±5.2) 0.141 
3 32.6 (±4.2) 30.6 (±4.08) 0.051 
EF(%) 1 62  (37-75) 63 (47-76) 0.908 
 2 65.1 (±5.99) 62.9(±7.16) 0.163 
3 64.4 (±5.6) 61.9 (±5.9) 0.069 
LA (mm) 1 9 (6.1-13) 8.8 (6.9 – 14.2) 0.438 
2 8.5 (±1.25) 7.7 (±1.17) 0.009 
3 8.2 (±1.08) 7.9 (±1.02) 0.221 
LA/AO 1 1.33 (1.1 – 2.1) 1.58 (1.1 – 2.3) 0.001 
2 1.31 (±0.17) 1.36 (±0.18) 0.319 
3 1.3 (±0.13) 1.39 (±0.14) 0.06 
Data were shown as mean (± standard deviation) for normally distributed data and median (minimum–
maximum) for  non parametric data. 
LVIDD: left ventricle internal diameter during diastole, LVIDS: left ventricle internal diameter during 
systole, FS: Fractional shortening, EF: ejection fraction, LA: left atria, LA/AO: Left atria and aortic ratio 
This table shows significantly higher value of LVIDD index and LVIDS index in the SGA 
group than AGA group in all the analysis. LA/AO ratio was increased in SGA infants in 
comparison to AGA infants and this difference was statistically significant on first 
echocardiography but not on the second and third. As far as fractional shortening and 
ejection fraction is concerned, the difference between both the groups was not 
statistically significant.  
 Table 8 
Cardiac output and index 
Parameters AGA  (N=35) SGA MEAN (N=35) SIGNIFICANCE 
LVO (ml/kg/min) 1 197 (140 – 318) 209 (148 – 369) 0.037 
2 189 (±49.7) 192 (±28.2) 0.752 
3 177 (119 – 331) 207 (121 – 279) 0.012 
LVCI (ml/m2/min)1 2.6 (2.1 – 4.2) 2.5 (1.8 – 4.1) 0.075 
2 2.6 (1.5 – 4.1) 2.3  (1.5 – 2.8) 0.008 
3 2.5 (1.7 – 4.3) 2.4 (1.5 – 3.2) 0.299 
LVSV (ml/kg) 1 1.6 (1.1 – 2.5) 1.6 ( 1 – 3.1) 0.925 
2 1.5 (0.9 – 2.6) 1.6 (1.1 – 2.0) 0.585 
3 1.4 (0.9 – 2.6) 1.6 (1.1 – 2.5) 0.032 
RVO (ml/kg/min) 1 186 (115 – 310) 234 (168 – 395) <0.001 
2 235 (124 – 380) 263 (121 – 378) 0.077 
3 208 (139 – 369) 251 (149 – 444) 0.009 
RVCI (ml/m2/min) 1 2.6 (1.76 – 4.1) 2.8 (0.2 – 4.8 ) 0.229 
2 3.3 (±0.85) 3.1 (±0.75) 0.335 
3 2.9 (1.8 – 4.7) 3.0 (1.9 – 4.9) 0.553 
RVSV (ml/kg) 1 1.6 (±0.37) 1.9 (±0.55) 0.020 
2 1.9 (±0.50) 2.1 (±0.48) 0.264 
3  1.8 (±0.46) 2 (±0.41) 0.053 
Data were shown as mean (± standard deviation) for normally distributed data and median (minimum–
maximum) for  non parametric data. 
 LVO:left ventricular output, LVSV: Left ventricle stroke volume,RVO:right ventricular output, RVSV: right 
ventricular stroke volume.CI: cardiac index 
We found that SGA babies had higher LVO and RVO than AGA babies in all the 
analysis. The difference on LVO and RVO was statistically significant on day 1 and 3. 
Figure: 2 & 3 
 
LVO and LVSV had a downward trend over first 3 days in AGA group, but not in SGA 
group. 
 Table 9 
Mitral & tricuspid valve velocity measurements 
Parameters AGA MEAN (SD) SGA MEAN (SD) SIGNIFICANCE 
MV E (m/s) 1 0.51 (0.38 - 0.91) 0.49 (0.34 -0.9) 0.710 
2 0.54 (0.38 – 0.79) 0.43 (0.27 – 0.67) 0.001 
3 0.49 (0.33 – 0.81) 0.45 (0.34 – 0.67) 0.055 
MVA (m/s) 1 0.49 (±0.095) 0.49 (±0.090) 0.705 
2 0.49 (±0.091) 0.42 (±0.095) 0.004 
3 0.45 (0.32 – 0.77) 0.43 (0.29 – 0.64) 0.215 
MV E/A 1 1.09 (0.8 – 2.87) 1.07 (0.68 – 1.69) 0.375 
2 1.08 (0.51 – 1.81) 1.07 (0.53 – .923) 0.756 
3 1.04 (0.73 – 1.91) 1.02 (0.76 – 1.84) 0.347 
E1 (m/s) 1 0.05 (0.3 – 0.06) 0.040 (0.03 –0.06) <0.001 
2 0.05 (0.3 – 0.07) 0.04 (0.02 – 0.06) <0.001 
3 0.05 (0.04 – 0.07) 0.04 (0.03 – 0.06) 0.001 
E/E1 1 11.35 (6.6 – 19.4) 12.3 (7.3 – 21.9) 0.128 
2 10.83 (6.7 – 15.8) 9.33 (5.9 – 21.1) 0.597 
3 10.35 (6.8 – 18.2) 10.38 (6.9 – 18.7) 0.897 
TV E (m/s) 1 0.43 (±0.097) 0.44 (±0.116) 0.764 
2 0.46 (±0.09) 0.43 (±0.11) 0.150 
3 0.47 (±0.13) 0.42 (±0.09) 0.080 
TV A (m/s) 1 0.5 (±0.11) 0.51 (±0.10) 0560 
2 0.54 (±0.12) 0.47 (±0.099) 0.006 
 3 0.53 (±0.12) 0.49 (±0.09) 0.074 
TV E/A 1 0.91 (53 – 1.26) 0.91 (0.44 – 1.77) 0.621 
2 0.85 (0.53 – 1.42) 0.85 (0.6 – 1.61) 0.514 
3  0.89 (0.55 – 1.79) 0.93 (0.46 – 1.33) 0.729 
Data were shown as mean (± standard deviation) for normally distributed data and median (minimum–
maximum) for  non parametric data. 
MV: mitral valve, TV: tricuspid valve, E: early passive filling, A: late active filling. 
Table no 9 shows SGA and AGA infants had nearly same velocities of MVE, MVA, TVE 
and TVA on day 1. But on subsequent days (2&3) doppler velocities were markedly 
lower at both mitral and tricuspid Valve in SGA group than AGA group. There were no 
statistically significant differences in E/A ratio at both the AV valves. 
Figure- 4
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Figure 4 & 5 illustrates the difference in E and A velocities between AGA and SGA 
babies at mitral and tricuspid valve respectively. It can be clearly seen that on day 1 
both SGA and AGA infants had nearly same velocities. Subsequently, on day 2 and 3 
SGA group had markedly lower velocities at both mitral and tricuspid valves than AGA 
group. 
  
 Table 10 
Deceleration time 
 AGA  SGA  P value 
MV EDT (ms) 1 128 (81-271) 113 (64-160) 0.084 
2 126(71-236) 132(95-236) 0.235 
3 135 (±33) 123 (±32) 0.474 
TV EDT (ms) 1 138 (±35) 119(±42) 0.049 
2 148 (92-214) 135 (89-299) 0.144 
3 152 (±37) 144(±46) 0.182 
Data were shown as mean (± standard deviation) for normally distributed data and median 
(minimum–maximum) for  non parametric data. 
Figure-6 
 
EDT: E wave deceleration time 
Table no 10 and figure no 6 illustrates that SGA babies had lower Mitral and tricuspid E 
wave deceleration time than AGA babies during first 3 days of life.  
 Table 11 
SVC diameter, SVC velocity time integral and SVC flow 
Parameters AGA MEAN (N=35) SGA MEAN (N=35) P value 
SVC MAX Diameter (mm)1 5.3 (±0.58) 4.6 (±0.86) <0.001 
2 5.2 (±0.62) 4.3 (±0.39) <0.001 
3 5.1 (±0.56) 4.4 (±0.53) <0.001 
SVC MIN Diameter(mm) 1 3.8 (±0.45) 3.4 (±0.67) 0.008 
2 3.8 (±0.61) 3.2 (±0.50) <0.001 
3 3.6 (±0.54) 3.2 (±0.36) <0.001 
SVC MEAN Diameter (mm) 1 4.5 (±0.47) 4.1 (±0.75) 0.002 
2 4.5 (±0.55) 3.8 (±0.51) <0.001 
3 4.4 (±0.51) 3.8 (±0.36) <0.001 
SVC VTI (cm) 1 11.2 (±2.1) 9.3 (±2.0) <0.001 
2 12.9 (8.9-18.9) 10.9 (7.2-17.7) 0.001 
3 12.6 (±3.1) 10.9 (±2) 0.003 
  SVC Flow(ml/kg/min) 1 86.8 (48.9 – 120) 92.5 (59 – 224) 0.168 
2 98.2 (±22.4)  95.8 (±20.7) 0.654 
3 94.4 (±32.5) 98.0 (±22.6) 0.587 
Data were shown as mean (± standard deviation) for normally distributed data and median (minimum–
maximum) for  non parametric data. 
SVC: superior vena cava, VTI: velocity time integral.   
Table 11 outlines the SVC diameter, VTI and flow in the two groups during first 3 days 
of life. It can be seen that AGA group had significantly increased SVC mean diameter 
 and SVC VTI in comparison to SGA group on all the measurements. However, SVC flow 
values were not higher in AGA babies. 
Figure: 7 
 
  
  
Table 12 
Doppler velocimetry of coeliac, superior mesntric and 
anterior cerebral artery 
 AGA(n=35) SGA(n=35) p value 
CA PS 1 62.6(16.8) 54(11.2) 0.014 
2 73.1(20.8) 56.1(17.4) 0.001 
3 75.6(41-117) 63.2 (42.7-114.5) 0.023 
CA ED 1 12 (0-34.2) 10.2(0-36.3) 0.269 
2 21.4(6.8-46) 13.7 (0-39.3) 0.001 
3 18.9(0-39.3) 15.4 (8.5-32.5) 0.029 
CA PI 1 1.69(.78-16.9) 1.78 (0.69-3.49) 0.756 
2 1.18 (.63-2.16) 1.43 (0.84-2.32) 0.004 
3 1.51 (0.53) 1.60 (0.40) 0.441 
CA RI 1 0.82 (.53-1) 0.82(0.47-1) 0.915 
2 0.68 (0.09) 0.72 (0.09) 0.059 
3 0.73 (0.09) 0.76 (.09) 0.319 
SMA PS 1 63(14.8) 56.2(12.3) 0.043 
2 73 (18) 56.8(17.6) <0.001 
3 83.7(51.3-124.8) 68.4(49.6-104) 0.004 
SMA ED 1 13(0-32.7) 8.52(0-34.5) 0.064 
2 22.2(6.8-53) 13.7(0-32.5) <0.001 
3 20.5(10.3-54.6) 15.4 (0-46.1) 0.004 
SMA PI 1 1.58 (0.89-2.86) 1.88 (0.63-4.24) 0.093 
2 1.27 (0.66-2.18) 1.37 (0.75-2.69) 0.025 
3 1.42 (0.04) 1.66 (0.45) 0.029 
SMA RI 1 0.81 (0.55-1) 0.85 (0.47-1) 0.380 
2 0.70 (0.09) 0.74(0.09) 0.077 
3 0.72 (0.09) 0.76 (0.11) 0.106 
  AGA (n=35) SGA(n=35) P value 
ACA PSV 1 20(4.9) 18.8(5.5) 0.316 
2 25.7 (5.8) 18.7 (3.4) <0.001 
3 26.3(13.8-41) 22.6(14.4-33.9) 0.012 
ACA EDV 1 4.4(0-10.7) 4.4(0-10.7) 0.710 
2 7.5 (3.8-13.2) 5.6(2.5-10.7) 0.008 
3 6.9 (4.4-13.8) 7.5(5-12.5) 0.759 
ACA PI 1 1.56 (0.97-3.15) 1.38(0.87-2.86) 0.164 
2 1.15 (0.79-2.08) 1.13(0.75-1.72) 0.764 
3 1.24 (0.69-2.1) 1.09(0.74-1.63) 0.033 
ACA RI 1 0.79 (0.59-1) 0.75 (0.52-1) 0.440 
2 0.69 (0.09) 0.68 (0.08) 0.574 
3 0.70 (0.09) 0.66 (0.07) 0.055 
Data were shown as mean (± standard deviation) for normally distributed data and median (minimum–
maximum) for  non parametric data.CA: celiac artery, SMA: superior mesenteric artery, ACA: anterior 
cerebral artery, PSV: peak systolic velocity, EDV: end diastolic velocity, PI: pulsatility index, RI: Resistivity 
index   
Table 12 showsdoppler velocimetry and indices over first 3 days of life in ACA, CA and 
SMA in two groups: SGA and AGA.  
It can be seen that SGA babies had increased PI and RI in CA and SMA. The difference 
in these indices that were statistically significant on day 2 was PI of CA and SMA, and 
on day 3 were PI in SMA.  
SGA infants had lower PI and RI in the anterior cerebral artery than AGA in all the 
analysis. These differences were statistically not significant except PI on day 3. 
 Figure-8 
 
CA: celiac artery, SMA: superior mesenteric artery, ACA: anterior cerebral artery, PSV: peak 
systolic velocity, EDV: end diastolic velocity. 
Graph 7 shows the trend of peak systolic velocity and end diastolic velocity in anterior 
cerebral artery, celiac artery and superior mesenteric artery during the first 3 days of 
postnatal life in SGA and AGA infants. 
During the first 3 days of life AGA neonates had persistently and significantly higher 
peak systolic velocity than SGA babies in both CA and SMA during the first 3 days of 
life. On day 1 both group had similar end diastolic flow in CA and SMA. But, end 
diastolic flow was significantly increased in AGA newborn on day 2 and 3. 
SGA babies had higher peak systolic flow in ACA than AGA babies in all the analysis.   
 Table 13 
 
Timing of PDA closure 
 
 DAY 2 DAY 3 
AGA 23 (66%) 8 (23 %) 
SGA 23 (66 %) 9 (26%) 
Data were represented as number (percentage) 
Duct had closed in two third of babies in both the group on day 2. Duct closed on day 
3 in 31 out of 35 AGA babies and 32 out of 35 SGA babies. There was no difference in 
timing of ductal closure between both the groups. 
  
 DISCUSSION 
Small for gestational age infants have higher mortality and morbidities in comparison 
to appropriate for gestational age babies infants. Several studies have evaluated 
cardiac function of growth restricted babies in utero and have demonstrated 
myocardial dysfunction in them (41-48). It is possible that the compromise could 
continue in early postnatal life.  However, there is limited data in this regard in SGA 
babies during the early postnatal period. Hence, the need for studies to assess the 
myocardial function in SGA babies in early neonatal life.  
We studied cardiac function of thirty five term and late preterm SGA babies with birth 
weight less than third percentile for gestational age as cases and included gestational 
age matched AGA babies with birth weight between 10th and 90th percentile of 
gestational age as controls during first 3 days of life. We performed daily functional 
echocardiography on all the babies during the first 3 days of life. The mean time of 
performing echocardiography was 5 ( ±  1), 31 ( ± 3) and 59 ( ± 7) hours of life.  
Myocardial Performance Index (MPI) 
In 1996, myocardial performance index (MPI also known as the Tei index) was 
formulated and published by TeiChuwa that evaluates both systolic and diastolic 
function of the heart. MPI has been proved to be a reliable method for the evaluation 
of systolic and diastolic performance of left ventricle.   
MPI = IVCT + IVRT / ET  
 [includes the isovolumic contraction time (IVCT), the ejection time (ET) and the 
isovolumic relaxation time (IVRT)] (36). MPI is a ratio of time intervals. Hence, the 
calculation of the index is not dependent of ventricular volume measurement. In 
addition, blood pressure and heart rate do not affect the MPI. 
MPI is an expression of global ventricular performance because it includes both 
systolic and diastolic time interval. The higherthe MPI, the worse the ventricular 
performance. Systolic dysfunction results in a prolongation of isovolumic contraction 
time (IVCT) and a shortening of ejection time. Prolongation of isovolumic relaxation 
time (IVRT) happens because of abnormality in relaxation time which results from 
both systolic and diastolic dysfunction (49). 
We found statistically significant increase in Left ventricle MPI measured both by 
pulsed wave doppler and tissue doppler imaging (at septal and lateral wall) in the SGA 
babies as compared to AGA babies on all 3 evaluations. Similarly, right ventricle MPI 
measured by both pulsed wave doppler and tissue doppler imaging were increased in 
the SGA babies during the first 3 days of life. The difference was statistically significant 
on all the occasions except day 3 RIMP value which was increased but did not reach 
statistical significance (table 2). 
Our study has also shown a significant reduction in ejection time of both left and right 
ventricles in SGA babies in contrast to AGA babies, which were measured by both 
pulsed wave doppler and tissue doppler (table 3 ). 
These findings are similar to other studies which have studied the myocardial 
performance index in growth restricted infants in the immediate newborn period, 
 after 72 hours and also in fetal life. They corroborate the hypothesis that SGA infants 
have myocardial dysfunction not only in fetal life but also in the newborn period. 
Altin H et al documented higher LV and RV MPI measured by pulsed wave doppler and 
tissue wave doppler in the SGA group than the control group (p < .001) at 72th 
postnatal hours of life as observed in our study (27). 
Studies done in utero on growth restricted babies have similar increased MPI as seen 
in our study. Comas et al found that in comparison to controls, growth restricted 
fetuses had a non-significant trend to increase left MPI.Their findings also supported 
the fact that growth restricted fetuses had subclinical cardiac dysfunction (29). 
Similarly, Cruz-Martinez RO et al found that SGA fetuses had significantly higher MPI 
as compared to controls (30). 
Based on significantly higher MPI of both ventricles and reduced AVET and PVET in the 
SGA group in comparison to the AGA group during first 3 days of life, it can be 
concluded that late preterm and term SGA babies have compromised myocardial 
function during the first 3 days of postnatal life. 
Hemodynamic parameters 
We found significant increased heart rate  in the SGA babies as compared to AGA 
babies during the first 3 days of life ( p  value on day 1,2 and 3 were <0.001, 0.007 and 
0.003 respectively). There were no differences in the systolic, diastolic and mean BP 
between the groups (table 4). Growth restricted babies have sympathetic stimulation 
 as an in-utero response (50). The increased heart rate in SGA babies in first 3 days of 
life may be an indication that sympathetic stimulation was still continuing. 
Altin  et al also had similar findings in their study. The SGA group had higher heart rate 
than those of controls (p< 0.001 at 72 hours of age) and similarly there was no 
difference in the blood pressure between the two groups (27). 
Metz et al in their study of preterm SGA babies (mean gestational age 31.6 weeks) 
have described significantly lower heart rate in SGA in comparison to AGA babies at 
birth (p < 0.001) but found no difference in the heart rate during the first week . There 
were no difference in mean BP but SGA babies had significantly lower systolic BP prior 
to discharge (p < 0.001) (32). 
Contrary to our findings Sehgal et al have described significantly higher systolic, 
diastolic and mean blood pressure in term SGA babies at 75±7 hours of life (34). 
Cardiac Dimension 
In the current study, SGA babies had significantly increased left ventricular internal 
diameter during diastole and systole as manifested in LVIDD and LVIDS indices in 
comparison to AGA babies, in the first 72 hours (table 7). Similarly, Left atrial aortic 
ratio (LA/AO) was higher in SGA babies than AGA babies. The difference in LA/AO ratio 
was statistically significant on day 1 and 3. This suggests that SGA babies have a more 
dilated left atrium and ventricle as compared to AGA babies. Excessive dilatation was 
observed throughout the cardiac cycle. 
 Recently, several studies have observed many changes in cardiac structure in growth 
restricted babies. Chronically compromised supply of oxygen and nutrition, 
accompanied by higher placental vascular resistance leads to pressure and probably 
volume overload of the fetal heart, which results in abnormal cardiac function. 
Consequently, a cardiac remodelling response is triggered by increased wall stress on 
the developing myocardial fibers (51). Contrary to normal conditions, a developing 
heart that has compromised supply of oxygen and nutrition does not develop the 
hypertrophic changes in response to mild pressure overload. Rather it compensates to 
the increased wall stress only by dilatation of the cardiac chamber (52).  Left 
ventricular dilatation has also been observed in an animal study where IUGR was 
induced experimentally by exposure to hypoxia (50). 
Altin  et al studied 30 term SGA babies at 72 hours of postnatal life and found higher 
value of LVIDD index in SGA group as compared to AGA group.  The findings were 
similar to our study. On follow up they observed that SGA babies had persistently 
higher values of LVIDD index than controls at 6 months of life (27). 
Similar to our findings, Sehgal et al also described significantly dilated atria in SGA 
infants in comparison to AGA infants in first 2-5 days of life. The mean of LA : AO in 
SGA  and AGA babies were 1.8 and 1.3 respectively (p<0.001) (34). 
Systolic Function: 
In our study we assessed the systolic function of left ventricle on the basis of fractional 
shortening (FS), ejection fraction (EF), area shortening (AS), left ventricle output(LVO), 
 stroke volume (LVSV), ejection time (AVET), isovolumic contraction time (IVCT) and 
myocardial performance index (MPI). 
Lee et al noticed limited contractility of the ventricular septum in the first week of life 
and suggested that area shortening (AS) should be used in place of fractional 
shortening during the first week (38).  In the current study we have used AS to assess 
contractility of left ventricle and this was found to be similar in both the groups. 
On all three analyses, we did not find any difference in EF, FS and AS between the two 
groups (table 6 and 7). SGA babies had increased LVO when compared to AGA babies 
during the first 3 days of life. The difference was statistically significant on day 1 and 3. 
LVO and LVSV decreased over time in AGA group, but not in SGA group (figure 2 & 3). 
Closure of ductus arteriosus could possibly explain this finding in AGA group. With 
closure of ductus the left to right shunting decrease leading to progressive decrease in 
the LVO in the AGA babies. However, in SGA babies LVSV and LVO remain elevated 
despite no difference in the timing of ductal closure between the 2 groups (table 13). 
The SGA babies also had significant increase in heart rate. Growth restricted babies 
have sympathetic stimulation as an in-utero response (50). The increased LVSV, LVO 
and HR in SGA babies may be indication that sympathetic stimulation was still 
continuing.  
Similar to our study Leipälä JA et al had also demonstrated increased LVO in the first 
4-6 days of life in the SGA group as compared to the AGA group. They also studied the 
intravascular volume between the two groups and found no difference in the initial 
days. So they concluded that increase in the LVO was not due to an increased preload 
(33). 
 Similarly, Martinussen et al had also observed increase in cardiac output in SGA 
infants on day 1 and they attributed their findings to compensatory response to fetal 
tissue hypoxia (53). 
There have been varying results while observing EF and FS in SGA babies and 
comparing them with AGA babies among various investigators. In the current study EF 
and FS were similar in both the SGA and AGA groups during the first 3 days of life. Our 
findings were similar to Altin  et al. The also observed no difference in EF and FS 
between the two groups at 72 hours of life (27). However, Sehgal  et al found a 
significant lower value of fractional shortening, stroke volume and left ventricular 
output in SGA babies (34). 
LIMP and AVET have been discussed earlier. In both the groups IVCT values were 
similar.  
Diastolic Function 
To evaluate the diastolic function of heart we have studied E wave (peak velocities of 
the early passive wave), A wave (late active wave), E/A ratio, E wave deceleration time 
(EDT), at both the AV valves, and isovolumic relaxation time (IVRT) of both left and 
right ventricles. The ratio of the mitral E wave to the tissue Doppler E1 was also 
measured. 
Diastolic dysfunction is characterized by reduced E and A wave velocities, increased 
E/A ratio, and prolonged or reduced EDT and prolonged IVRT.  
 In our study, on day 1, SGA neonates had nearly same velocities of MVE, MVA, TVE 
and TVA as AGA neonates but markedly lower values than AGA neonates on 
subsequent days (figures 4 & 5). There were no statistically significant differences in 
E/A ratio at both the AV valves (Table 9). Mitral and tricuspid E wave deceleration 
time was lower in SGA babies in comparison to AGA babies during first 3 days of life 
(table 10 and graph 6). These findings suggest decrease compliance of both ventricles 
in SGA babies (49). 
In both the groups E/E1 and IVRT were similar (table 9 and table 5 respectively). 
Sehgal  et al had also described diastolic dysfunction in SGA babies. They found lower 
E and A wave velocities, increase E/A ratio, prolonged IVRT and EDT (34). 
Diastolic dysfunction in the SGA group has also been described by Altin et al at 72 
hours of life. E/A ratio and E/E1 ratio were higher in the SGA babies in comparison to 
AGA babies (27).   
Superior Vena Cava (SVC) Flow 
SVC flow is an indirect measure of cardiac output. As far as the requirements for 
Doppler volumetric measurement is concerned, the SVC flow fulfils it with good 
windows for both vessel diameter measurements and flow velocity. The advantage of 
using SVC flow as surrogate marker of systemic blood flow is that it is not affected by 
the shunting that happens at both ductal and atrial level in the first 24 hours of life. 
Mohiaddin et al, using cine magnetic resonance velocity mapping in healthy adults, 
found mean SVC flow was 35% of cardiac output (54).  Nick Evans et al found a mean 
 SVC flow was 37% of cardiac output in the preterm neonates (39). There is no study 
describing SVC flow in SGA babies in term and late preterm population. 
In our study we have found that AGA infants have significantly higher SVC mean 
diameter (p values on day 1, 2 & 3 were 0.002, <0.001 and <0.001 respectively) and 
SVC VTI (p values on day 1, 2 & 3 were <0.001, 0.001 and 0.003 respectively) in 
comparison to SGA infants in all the analysis. When it comes to SVC flow we did not 
find a significant difference (p value on day 1, 2 & 3 were 0.168, 0.654 and 0.587 
respectively). This can be explained by significant higher heart rate in SGA babies than 
AGA babies. However, SGA babies had increased trend of SVC flow (figure 7) on day 1 
and 3 in comparison to AGA babies. Drayton MR and Skidmore R have shown that the 
SVC flow can be used as surrogate marker of cerebral blood flow as it represents 
approximately 80% of the blood flow returning from the brain (55).  
From these results it can be concluded that in the first 72 hours of life, the blood 
supply to the brain is well maintained in the SGA babies similar to AGA babies. This 
conclusion can also be supported by our finding from doppler velocimetry of anterior 
cerebral artery which did not show any significant difference between two groups 
(Table 12). 
Indices in Coeliac, Superior Mesentry and Anterior Cerebral 
Arteries 
Doppler indices provide information about blood flow and vascular impedance that is 
difficult to obtain from absolute velocity alone. The resistive index and pulsatility 
index are the two most commonly used indices. The advantage of using these indices 
 obviates the need of angle correction and size of the vessel, as it cancel each other. 
These indices provide useful information about blood flow and vascular impedance of 
small vessels like coeliac, superior mesenteric and anterior cerebral artery  (56). 
The resistive index (RI) and pulsatility index (PI) can be calculated by using the 
following equations: RI = (PSV - EDV)/PSV and PI = (PSV - EDV)/ MV respectively. PSV is 
the peak systolic velocity, EDV is the end-diastolic velocity and MV is the mean flow 
velocity during the cardiac cycle  (57).  Taking the mean velocity into account makes PI 
the most sensitive marker in differentiating abnormal waveforms.  
In our study we found lower values of PI and RI in the anterior cerebral artery in SGA 
group than AGA group in the first 3 days of life which was suggestive of lower vascular 
impedance in SGA infants. However, these differences were statistically not significant 
except PI on day 3 (table 12). The peak systolic velocity and end diastolic velocity of 
ACA in both the group have shown an upward trend over 3 days (figure 8).    
Muniz et al have studied anterior cerebral artery doppler velocimetry in SGA infants 
during 24-48 hours after birth. They noticed decreased cerebral blood flow velocity in 
the ACA and significantly reduced peak systolic and mean velocity in the SGA babies in 
contrast to AGA babies (58). 
Cheung YF et al have performed serial Doppler studies of the anterior cerebral artery 
in SGA babies and compared that to AGA babies in the first 5 days of life. RI decreased 
over the initial five days in AGA babies, while both the PSV and EDV increased. In the 
first 24 hours of life RI was significantly lower in SGA infants. They related this to 
increased EDV of ACA as a continuation of the intrauterine adaptation (59). 
 Doppler velocimetry of superior mesenteric artery has been studied in preterm and 
SGA babies as a predictor of feed intolerance with variable correlation(60,61). 
Our study has shown a trend towards higher vascular resistance in CA and SMA in SGA 
babies in comparison to AGA babies during the first 72 hours of life. Both CA and SMA 
had higher PI and RI in the SGA group. The differences in these indices were 
statistically not significant in CA except PI of CA on day 2.In SMA the differences in RI 
was statistically insignificant on all the 3 days but PI showed a significant increase in 
the SGA babies on day 2 and 3.    
The peak systolic velocity was significantly and persistently higher in the AGA babies in 
both CA and SMA during the first 3 days of life. The end diastolic flow of CA and SMA 
was similar on day 1 in both the groups but on day 2 and 3, AGA neonates had 
significantly increased flow.  
Kivilevitch et al in a cross-sectional prospective study described the doppler 
velocimetry of superior mesenteric artery in growth restricted fetus from 19 to 38 
weeks of gestation as compared to normal growing fetus. Growth restricted fetuses 
had a lower pulsatility index in superior mesenteric artery in comparison to AGA 
fetuses which suggested decreased vascular impedance in SMA among the growth 
restricted foetuses (62).  However, in our study PI in SMA was higher in SGA group in 
first 3 days of life. This could be because of difference in the characteristics of study 
population. In our study 23 percent of the SGA babies had abnormal doppler in 
contrast to 100 percent in the study by Kivilevitch et al. 
 Similar to our finding, Bora et al described lower peak systolic velocity in SGA babies 
as compared to AGA babies (60). 
In our study SGA babies have shown a trend of lower blood flow and higher vascular 
resistance in CA and SMA, in comparison to AGA babies during first 3 days of life.  
PDA Closure:  
We have also looked into timing of closure of ductus in both the groups. Sixty six 
percent of PDA had closed on day 2 in both the groups. By day 3, ductus was closed in 
89 % of SGA babies and 91 % of AGA babies.  There was no difference in the timing of 
closure of PDA in both the groups. 
 
We observed in our study that volume independent parameters of cardiac function 
like MPI are significantly increased and mitral valve E1 are significantly lower in SGA 
babies as compared to AGA babies. Whereas volume dependent parameters like 
fractional shortening, ejection fraction, area shortening and stroke volumes are similar 
in both the groups. We also found higher value of left ventricle internal diameter 
index during diastole and systole (LVIDD index and LVIDS index) and LA:AO ratio in 
SGA babies in comparison to AGA babies which is suggestive of volume overload in 
SGA babies. It may be postulated that increased volume overload in SGA babies 
compensate for compromised myocardial performance by increasing cardiac 
contractility in response to increased preload as per Sterling’s law.    
 CONCLUSIONS 
 
 SGA babies had significantly higher index of myocardial performance in both 
the ventricles and ejection time was significantly reduced in left and right 
ventricles as compared to the AGA babies in all the analysis. It can be 
concluded that myocardial function was compromised during the first 3 days 
of postnatal life among late preterm and term SGA babies.  
 In comparison to AGA babies, SGA babies had significantly increased heart rate 
during the first 3 days of life. But, the systolic, diastolic and mean BP was 
similar in both the groups. 
 SGA infants had dilated left atrium and ventricle in comparison to AGA infants. 
Excessive dilatation was observed throughout the cardiac cycle. 
 When it comes to systolic function SGA babies had fractional shortening, 
ejection fraction and area shortening similar to AGA babies. Left ventricular 
cardiac output was increased in SGA group in comparison to AGA group but 
the difference was not statistically significant.  
 SGA babies had decreased compliance of both the ventricles in comparison to 
AGA infants. 
 Both AGA and SGA babies had no statistical difference in SVC flow. Hence, it 
can be concluded that the blood supply to the brain in SGA babies is well 
maintained as in the AGA babies. 
  The SGA group had lower values of PI and RI in the anterior cerebral artery as 
compared to AGA group in all the analysis which suggested that the vascular 
impedance was lower in ACA in SGA infants. 
 SGA babies showed a trend of lower blood flow and higher vascular resistance 
in CA and SMA, in comparison to AGA babies during first 3 days of life.  
 There was no difference in timing of ductus arteriosus closure in both the 
groups. 
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Abbreviations 
SGA: small for gestational age 
AGA: appropriate for gestational age 
FGR: fetal growth restriction 
PIH: pregnancy induced hypertension 
BSA: body surface area 
HR: heart rate 
BP: blood pressure 
MPI: myocardial performance index 
PWD: pulsed wave doppler 
TDI: tissue doppler imaging 
LIMP: left ventricle index of myocardial performance 
RIMP: right ventricle index of myocardial performance 
LVET: left ventricle ejection time 
RVET: right ventricle ejection time  
MV: mitral valve 
TV: tricuspid valve 
IVRT: Isovolumic relaxation time 
IVCT: Isovolumic contraction time 
LVOT: left ventricle outflow tract 
RVOT: right ventricle outflow tract 
LVIDD: left ventricle internal diameter during diastole 
LVIDS: left ventricle internal diameter during systole 
FS: fractional shortening 
 EF: ejection fraction 
LA: left atria 
LA/AO: left atriaand aortic ratio 
AS: area shortening 
LVO: left ventricular output 
LVSV: left ventricle stroke volume 
LVCI: left ventricle cardiac index 
RVO: right ventricular output 
RVSV: right ventricular stroke volume 
RVCI: light ventricle cardiac index 
MV: mitral valve 
 TV: tricuspid valve 
E: early passive filling 
A: late active filling 
EDT:E wave deceleration time 
SVC: superior vena cava 
VTI: velocity time integral 
CA: celiac artery 
SMA: superior mesenteric artery 
ACA: anterior cerebral artery  
PSV: peak systolic velocity 
EDV: end diastolic velocity 
PI: pulsatility index 
RI: resistivity index  
  
 A prospective observational study comparing cardiac function of small for 
gestational age with appropriate for gestation age babies using serial 
echocardiographic studies  
Patient information sheet 
Dear Parents, in countries like India, about 25 % of the babies do not grow well before birth. 
One third of the babies admitted in nursery are not well grown. These growth restricted 
babies have more short term and long term problems  in comparison to normal babies. These 
babies are more prone to have birth asphyxia, low body temperature, low blood pressure, 
bleeding from lung, low blood sugar, high hemoglobin, kidney failure and lower blood counts. 
In adult life, they are at high risk of developing high blood pressure, diabetes and heart 
problems that can lead to heart attack. 
In our experience a large numbers of growth restricted babies have compromised heart 
function and they require medicine to support the heart function. Bedside heart scan in these 
babies have shown compromised heart function.  
There are researches that have evaluated the heart function of growth restricted babies 
before birth, showing problem with the heart function in them. But there is very limited 
information about heart function in them after birth. 
We plan to do a study in the babies who are not well grown.   
What we want to do? 
We will assess the heart functions of growth restricted babies who are born between 34 to 41 
weeks of pregnancy by serial heart scan (echo) and compare this with normal babies of the 
same maturity.  We will do three serial heart scan (echo) at 0-8, 24-36 and 48-72 hours of age. 
How will it help? 
After early recognition of problem in the heart function, judicious use of medicine that 
support heart function and appropriate fluid administration may improve the overall outcome 
in this group of babies. 
Do I have to allow my baby to be part of this study? 
No, you are free to refuse the inclusion of your baby in the study.  
Even if you choose for your baby not to be included in the study your baby will be treated as 
per the procedure followed in this neonatal unit. 
If you allow your baby to be part of the study you can still withdraw your baby from the study 
at anytime.  
 
Please feel free to contact for any clarifications. 
Contact detail: Dr Manish Kumar 
Department of Neonatology, CMCH, Vellore  
Phone: 0416-228-3311/3673, Email: manish@cmcvellore.ac.in   
 CONSENT FORM 
BABY’S NAME 
HOSPITAL NUMBER: 
 
Title: A prospective observational study comparing cardiac function of 
small for gestational age with appropriate for gestation age babies using 
serial echocardiographic studies  
Name of Researcher: Dr Manish Kumar 
I confirm that I have read and understand the information sheet for the above 
study and have had the opportunity to ask questions. 
 
I understand that the participation of my baby in this study is voluntary and that 
I am free to withdraw my baby from the study at any time, without giving any 
reason, without the medical care or legal rights of my baby being affected. 
 
I understand that sections of any of the medical notes of my baby may be 
looked at by responsible individuals from the study organisers or from 
regulatory authorities where it is relevant to my baby taking part in research. I 
give permission for these individuals to have access to the records of my baby. 
 
I agree for my baby to take part in the above study. 
 
Name of Parent:      Name of doctor: 
Signature:       Signature: 
Date:        Date: 
 
  
 Ma;tpd; jiyg;G: njhlH vf;NfhfhHbNahfpuhgpf;]; Ma;Tfis gad;gLj;jp fUtsHfhyj;jpw;F 
rpwpajhf gpwe;j Foe;ijfSf;Fk; rhpahdmsthf gpwe;j Foe;ijfSf;Fk; ,ilNaahd 
,Ujaj;jpd; nray;ghLfis xg;gpLk; xU vjpHfhy cw;WNehf;fy; Ma;T. 
  
jfty; jhs; 
md;Gs;s ngw;NwhHfNs  
,e;jpah Nghd;w ehLfspy; 25rjtPjk; Foe;ijfs; gpwg;gjw;F Kd; fUg;igapy; rhpahf 
tsHtjpy;iy  (fUg;giapy; jilgl;l tsHr;rp)  kw;Wk; mtHfs; ,Uf;fNtz;ba msit tpl  
rpwpajhf gpwf;fpwhHfs;. ,tHfs; fUtsHfhy;jpw;F rpwajhf gpwe;j Foe;ijfs; (v];.[p.V) vd;W 
miof;fg;gLfpwhHfs;. cq;fs; Foe;ijiag;Nghd;W> eHrhpapy; mDkjpf;fg;gl;Ls;s Foe;ijfspy; 
%d;wpy; xU gq;F Foe;ijfs; ,e;jg; gphpit rhHe;jtHfs;. ,e;j tsHr;rp jilgl;l Foe;ijfis 
kw;w rhpahd msthf gpwe;j Foe;ijfNshL xg;gpLifapy; ,tHfSf;F mjpf FWfpa fhy kw;Wk; 
ePz;l fhy gpur;ridSk;; fhzg;gLfpwJ.   ,e;j Foe;ijfSf;F gpwg;G %r;Rj;jpzwy;> Fiwe;j 
cly; ntg;gepiy> Fiwe;j ,uj;j mOj;jk;> EiuaPuypy; ,Ue;J ,uj;jk; frpjy;> Fiwe;j ,uj;j 
rHf;fiu> mjpf cwPNkhFNshgpd;> rpWePuf NfhshW kw;wk; Fiwe;j ,uj;j mZf;fspd; 
vz;zpf;if Nghd;w Neha;fSf;F Mshfpd;wd.  nghpatHfshf thOk; NghJ ,f;Foe;ijfSf;F 
caH ,uj;j mOj;jk; Vw;gLtjw;Fk;. rHf;fiu Neha; Vw;gLtjw;Fk; ,ja rk;ge;jkhd gpur;ridfs; 
cUthtjw;Fk; mjpf Mgj;J cs;sJ ,jdhy; khuilg;G Vw;glyhk;. 
vq;fs; mDgtj;jpy; nghpa vz;zpf;ifapy; ,t;thW tsHr;rp jilgl;l Foe;ijfSf;F Fiwthd 
,ja nray;ghLk; kw;Wk; ,ja nray;ghl;bw;F kUj;Jt cjtpAk; Njitg;gl;lJ.  
,f;Foe;ijfSf;F nra;ag;gl;l ,ja ];Nfd;fs; ,it FiwghLila ,ja nray;ghl;il 
nfhz;bUg;gij fhl;LfpwJ. 
 
,t;thW tsHr;rp jilg;gl;l Fioe;ijfs; gpwg;gjw;F Kd; ,ja nray;ghl;il fzpg;gjw;F 
nra;ag;gl;l Muha;r;rpfs; ,it mtHfs; Nkhrkhd ,ja nray;ghl;il nfhz;bUg;gij 
fhz;gpj;jd.  Mdhy; Foe;ij gpwe;j gpwF mtw;wpd; ,ja nray;ghL Fwpj;J Fiwe;j jfty;fNs 
cs;sd. 
 
ehq;fs; vd;d nra;ag;NghfpNwhk;? 
 
ehq;fs;; 34-41 thu fUtsH fhyj;jpw;Fs; gpwe;j tsHr;rp jilgl;l Foe;ijfspd; ,ja 
nray;ghl;il njhlHr;rpahf ,ja ];Nfd; nra;J mtw;iw rhjhud mstpy; gpwe;j Foe;ijfspd; 
,ja ];NfNdhL xg;gpl;L ghHg;Nghk;. ehq;fs; 3 njhlH ,ja ];Nfd;fis 0-8> 24-36 kw;Wk; 48-72 
kzp Neu tajpy; nra;a ,Uf;fpNwhk;. ,ja ];Nfd; typ Vw;gLj;jf;$bajy;y  my;yJ clYf;Fs; 
nrYj;jp nra;ag;gLtjpy;iy. ,J ePq;fs; fHg;gkhf ,Uf;Fk;NghJ nra;j ];Nfd; Nghd;wjhFk;.  
 
,J vt;thW cjTk;? 
 Muk;gj;jpNyNa ,ja nray;ghl;by; gpur;rid ,Ug;gij fz;Lgpbj;j gpwF> ehk; mjwF cjTk; 
kUe;Jfis gad;gLj;Jtjw;Fk;  jput czit khw;wpaikf;fTk; mjd; %yk; ,j;jifa 
Foe;ijfspd; xl;Lnkhj;j tpisTfis Nkk;gLj;j KbAk;.  
 
ehd; vd; Foe;ijia ,e;j Ma;tpy; gq;Fnfhs; mDkjpf;fNtz;Lkh? 
 
fl;lhakpy;iy> ePq;fs; cq;fs; Foe;ijia ,e;j Ma;tpy; NrHg;gjw;F Rje;jpukhf kWf;fyhk;.  
ePq;fs; cq;fs; Foe;ijia ,e;j Ma;tpy; NrHg;gjw;F kWj;jhYk; ,e;j gr;rpsq;Foe;ijfs; gphptpy; 
filgpbf;fg;gLk; newpKiwfs; gb cq;fs; Foe;ijf;F rpfpr;ir mspf;fg;gLk;. ePq;fs; cq;fs; 
Foe;ijia vg;nghOJ Ntz;LkhdhYk; ,e;j Ma;tpypUe;J tpyf;fpf;nfhs;syhk ;. 
 
ve;j tpsf;fKk; ngw jaT nra;J njhlHG nfhs;sTk; 
 
njhlHG nfhs;s 
Dr.Manish Kumar 
Department of Neonatology 
Christian Medical College Hospital, 
Vellore 
Phone: 0416-228-3311/3673 
e mail: manish@cmcvellore.ac.in 
 
 xg;Gjy; 
 
jiyg;G: njhlH vf;NfhfhHbNahfpuhgpf;]; Ma;Tfis gad;gLj;jp fUtsHfhyj;jpw;F rpwpajhf 
gpwe;j Foe;ijfSf;Fk; rhpahdmsthf gpwe;j Foe;ijfSf;Fk; ,ilNaahd ,Ujaj;jpd; 
nray;ghLfis xg;gpLk; xU vjpHfhy cw;WNehf;fy; Ma;T. 
 
Ma;thshpd; ngaH: kUj;JtH kdP]; FkhH  
Ma;T vz; 
Nehahspapd; ngaH   
 
gpwe;j Njjp taJ(tUlj;jpy;) 
 --------------------------------------------------d; je;ij / jha;;  
Mfpa  ----------------------------------------------- ehd;  
 
(fl;lj;jpy; FwpaplTk); 
1. ehd; ,e;j Muha;r;rpapd; jfty; mwpf;ifia gbj;J Ghpe;Jnfhz;Nld; vd;W 
cWjpaspf;fpd;Nwd;. NkYk;> ,e;j Muha;r;rp gw;wp Nfs;tpfs; Nfl;f  vdf;F 
re;jHg;gkspf;fg;gl;lJ vd;Wk; cWjpaspf;fpd;Nwd.  
 
2. ,e;j Muha;r;rpapy; gq;Nfw;gJ vd; jd;dpr;irahd KbT vd;Wk; ,e;j Muha;r;rpapypUe;J 
vg;nghOJ Ntz;LkhshYk; ve;j fhuzKkpy;yhky; tpLtpj;Jnfhs;syhk; vd;Wk; mJ vdf;F 
mspf;fg;gLk; kUj;Jt rpfpr;ifiaAk; vq;fsJ rl;lG+Htkhd chpikiaAk; ve;j tpjj;jpYk; 
ghjpf;fhJ vd GhpeJnfhz;Nld; vd;W cWjpaspf;fpd;Nwd;.  
 
3. ,e;j Ma;tpd; MjuthsHfs; kw;Wk; mtH rhHghf Ntiy nra;gtHfs;> newpKiwfs; FO 
kw;Wk; fl;Lg;ghl;L mjpfhhpfs; vd; kUj;Jt gjpNtLfis  ehd; ,e;j Ma;tpypUe;J 
tpyfpf;nfhz;lhYk; ghHf;fyhk; vd;W Ghpe;J nfhz;Nld;. ,jw;F ehd; xg;Gjy; mspf;fpd;Nwd; 
vd;id gw;wpa ve;j jftYk; %d;whtJ egUf;F njhpag;gLj;jg;glhJ vd;Wk; gpuRhpf;fglhJ 
vd;Wk; Ghpe;J nfhz;Nld;. 
 
4. ,e;j Ma;tpy; gq;F nfhs;s nra;a jd;dpr;ifahf xg;Gjy; mspf;fpd;Nwd;. 
 
ifnahg;gkpl;lthpd; ngaH     Mahthshpd; ngaH 
 
ifnahg;gk; (m) ngUtpuy; Nuif   Ma;thshpd; ifnahg;gk;   
Njjp        Njjp  
 PROFORMA FOR SGA HEART STUDY 
Serial no 
Name  
Hospital no 
Mother’s hospital no 
BIRTH DETAIL 
Date of birth 
Time of birth 
Sex : Boy/Girl 
Gestational age (weeks)   Dating SCAN :     
 Dubowitz: 
Birth weight (gms) 
Length (cms) 
Head circumference (cms) 
SGA/AGA 
If SGA: 
Symmetrical / Asymmetrical /Mixed  
Mode of delivery:  Normal   LSCS  Forcep  Vaccum 
Indication: 
APGAR:  1 MIN   5 MIN 
Maternal history 
Pre-pregnancy weight    Height 
Parity 
PIH: Y/N 
Diabetes: Y/N 
Heart disease: Y/N 
Anemia: Y/N 
OtherS 
 Antepartum hemorrhage 
MSAF 
 Antenatal scan 
IUGR:   y/n 
Umbilical artery Doppler: 
S/D ratio  PI 
Middle cerebral artery 
Vmax  S/D  PI   
Amniotic fluid index: 
RISK FACTOR FOR SEPSIS:   Yes/No 
PPROM/ PROM> 24 hours/ Maternal fever>100.4°F/ Foul smelling liquor/PV > 4(after rupture 
of membrane)/Untreated UTI/GBS colonisation/Previous baby with GBS sepsis 
Newborn parameters: 
Hemoglobin:  
Platelet 
Total WBC count: 
Neutropenia  
IgM 
Blood culture 
CRP 
Time     
Clinical parameters 0-8 24-36 48-72 
Heart Rate    
Respiratory rate:    
CRT    
Blood pressure    
Liver size    
Murmur    
SPO2    
Acidosis    
Inotropes    
Normal saline bolus    
 
 If Inotropes was used: specify: dopamine/dobutamine/adrenaline/milrinone 
Maximum dose used:     Duration: 
If acidosis: specify the Lowest value for: Ph: HCO3:   BE:  Duration 
acidosis persisted: 
Neonatal complications:  
Hypothermia: y/n 
Hypoglycemia: y/n 
Hyperbilirubinemia: y/n 
Polycyathemia: y/n 
Neonatal seizures: y/n 
Pulmonary haemorrhage: y/n 
PPHN: y/n 
Acute kidney injury: y/n 
NEC stage 2 /3: y/n 
  
  
 
  
  
     
           
       
 
 
 
 
